Innovation activity in the Lisinopril market has been, as a whole, growing over the last 5 years, with a 25.87% average growth rate. The highest annual increase came in 2018 when MSD filed 6 new patents within the space.

The 369 technologies are being applied within 10 different categories, the fastest growing of which is Biochemistry with a 53.33% increase in new patents filed over the past 5 years. The category “Medical” is seeing a lot of filings by new entrants, so it might be an emerging space worth looking into.

For deeper insights on the pharmaceutical industry or another area of focus, visit ipcypris.com and get started using the innovation dashboard and custom reports.

There are 631+ commercial entities operating in the nuclear energy space based on IP ownership or if they’ve referenced the key terms in market news, about us pages, or SEC filings. Across the board, China takes the lead.

Over the past year, the most active commercial entities IP filing were SHANGHAI NUCLEAR ENG RES & DESIGN INST CO LTD, BEIJING INSTITUTE TECH, and CHINA NUCLEAR POWER ENG CO LTD.

Among patents filed by the most active entity, SHANGHAI NUCLEAR ENG RES & DESIGN INST CO LTD, were those focused on:

– Nuclear energy steam supply system
– Dual-purpose transportation container for uranium dioxide pellet powder
– Sewage discharging and heat supplying system of steam generator of nuclear power station

China accounts for 518 patent applicants (67.9% of patent applicant activity), followed by Russia and the World Intellectual Property Organization.

For actionable innovation intelligence in your industry, visit ipcypris.com. To browse recent patent filings for free, explore our our global patent search engine.